1 1394 139 IMPACT OF YOGA BASED LIFESTYLE INTERVENTION ON PSYCHOLOGICAL STRESS AND QUALITY OF LIFE IN THE PARENTS OF CHILDREN WITH RETINOBLASTOMA. BACKGROUND: CHILDHOOD CANCERS ARE ASSOCIATED WITH A PSYCHOLOGICAL BURDEN TO THE PARENTS AND HENCE, DECLINE THEIR MENTAL AND PHYSICAL HEALTH AND OVERALL QUALITY OF LIFE. PURPOSE: THE PURPOSE OF THE PRESENT STUDY IS TO INVESTIGATE THE IMPACT OF 12-WEEKS YOGA BASED LIFESTYLE INTERVENTION ON PSYCHOLOGICAL STRESS AND QUALITY OF LIFE IN THE PARENTS OF CHILDREN AFFECTED WITH RETINOBLASTOMA. METHOD: SINGLE ARM PROSPECTIVE CLINICAL TRIAL CONDUCTED FROM OCTOBER 2015 TO OCTOBER 2017 AT THE LABORATORY FOR MOLECULAR REPRODUCTION AND GENETICS, DEPARTMENT OF ANATOMY, ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI, INDIA. A PRE-TESTED 12-WEEKS YOGA BASED LIFESTYLE INTERVENTION INCLUDED ASANAS (PHYSICAL POSTURES), PRANAYAMA (BREATHING EXERCISES), DHYANA (MEDITATION), RELAXATION TECHNIQUES, LECTURES AND FILMS ON YOGA, INTERACTIVE SESSIONS AND INDIVIDUALIZED ADVICE WAS ADMINISTERED TO THE PARTICIPANTS. RESULTS: 12-WEEKS OF YOGA BASED LIFESTYLE INTERVENTION PROGRAMME LEADS TO A SIGNIFICANT IMPROVEMENT IN PSYCHOLOGICAL STRESS AND OVERALL QUALITY OF LIFE IN THE PARENTS OF RETINOBLASTOMA PATIENTS. THERE WAS A SIGNIFICANT IMPROVEMENT IN ALL THE DOMAINS (PHYSICAL HEALTH, PSYCHOLOGICAL HEALTH, SOCIAL RELATIONSHIPS, AND ENVIRONMENT) OF WHOQOL-BREF FROM BASELINE (DAY 0) TO 12-WEEKS OF YOGA BASED LIFESTYLE INTERVENTION. YOGA BASED LIFESTYLE INTERVENTION ALSO LED TO A SIGNIFICANT INCREASE IN THE LEVELS OF BRAIN DERIVED NEUROTROPHIC FACTOR, DEHYDROEPIANDROSTERONE SULPHATE, SIRTUIN 1 AND DECREASED THE CORTISOL AND IL-6 LEVELS. CONCLUSION: YOGA BASED LIFESTYLE INTERVENTION REDUCED THE SEVERITY OF PSYCHOLOGICAL STRESS AND RESULTED IN IMPROVEMENT IN OVERALL QUALITY OF LIFE AND UPREGULATION IN LEVELS OF SYSTEMIC BIOMARKERS OF NEUROPLASTICITY. YBLI MAY SERVE AS A BENEFICIAL THERAPY AND MAY ALSO ACT AS AN EFFECTIVE MEDIUM FOR BETTER STRESS MANAGEMENT TO DEVELOP BETTER COPING STRATEGIES IN THE PARENTS OF RETINOBLASTOMA PATIENTS. 2019 2 2009 38 SUBJECTIVE SLEEP QUALITY AND HORMONAL MODULATION IN LONG-TERM YOGA PRACTITIONERS. YOGA REPRESENTS A FASCINATING MIND-BODY APPROACH, WHEREIN BODY MOVEMENTS (ASANA), BREATHING EXERCISES (PRANAYAMA) AND MEDITATION ARE INTEGRATED INTO A SINGLE MULTIDIMENSIONAL PRACTICE. NUMEROUS BENEFICIAL MENTAL AND PHYSICAL EFFECTS HAVE BEEN CLASSICALLY ASCRIBED TO THIS HOLISTIC ANCIENT METHOD. THE PURPOSE OF THE PRESENT STUDY HAS BEEN TO EXAMINE THE EFFECTS OF LONG-TERM YOGA PRACTICE ON SUBJECTIVE SLEEP QUALITY (SSQ) AND ON SEVERAL HORMONAL PARAMETERS OF THE HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) AXIS. TWENTY-SIX SUBJECTS (16 EXPERIMENTAL AND 10 CONTROLS) WERE RECRUITED TO BE PART OF THE STUDY. EXPERIMENTAL SUBJECTS WERE REGULAR YOGA PRACTITIONERS WITH A MINIMUM OF 3 YEARS OF PRACTICE. BLOOD SAMPLES FOR THE QUANTIFICATION OF ADRENOCORTICOTROPIC HORMONE (ACTH), CORTISOL AND DEHYDROEPIANDROSTERONE SULPHATE (DHEA-S) WERE DRAWN FROM ALL SUBJECTS. LIKEWISE, THE PITTSBURGH SLEEP QUALITY INDEX (PSQI) WAS EMPLOYED TO ASSESS SSQ. AS STATISTICAL ANALYSIS, MANN-WHITNEY U-TEST WAS PERFORMED. THE YOGA GROUP DISPLAYED LOWER PSQI SCORES AND HIGHER BLOOD CORTISOL LEVELS THAN CONTROL SUBJECTS. THEREFORE, IT CAN BE CONCLUDED THAT LONG-TERM YOGA PRACTICE IS ASSOCIATED WITH SIGNIFICANT PSYCHO-BIOLOGICAL DIFFERENCES, INCLUDING BETTER SLEEP QUALITY AS WELL AS A MODULATORY ACTION ON THE LEVELS OF CORTISOL. THESE PRELIMINARY RESULTS SUGGEST INTERESTING CLINICAL IMPLICATIONS WHICH SHOULD BE FURTHER RESEARCHED. 2009 3 2120 22 THE EFFECT OF YOGA TRAINING ON ENHANCEMENT OF ADRENOCORTICOTROPIC HORMONE (ACTH) AND CORTISOL LEVELS IN FEMALE PATIENTS WITH MULTIPLE SCLEROSIS. THE EFFECT OF 8 WEEKS YOGA TRAINING ON CORTISOL AND ADRENOCORTICOTROPIC HORMONE (ACTH) LEVELS IN FEMALE PATIENTS WITH MULTIPLE SCLEROSIS (MS) IS EXAMINED. TWENTY FOUR MS FEMALE PATIENTS WITH EXPANDED DISABILITY STATUS SCALE (EDSS) 1 TO 5.5 PARTICIPATED IN THIS STUDY AS THE SUBJECT. THE PARTICIPANTS WERE DIVIDED INTO CONTROL (N = 10) OR TRAINING GROUP (N = 14) RANDOMLY. TRAINING GROUP PERFORMED 90 MIN YOGA TRAINING PER SESSION, 3 DAYS A WEEK FOR 8 WEEKS. ASSESSMENTS INCLUDE BODY COMPOSITION MEASUREMENT AND BLOOD SAMPLING 48 H BEFORE FIRST SESSION AND 48 H AFTER THE INTERVENTION. THE RESULTS DEMONSTRATED THAT ACTH INCREASED AND CORTISOL DECREASED COMPARED TO THE CONTROL GROUP (P < 0.05); IN CONCLUSION, IT SEEMS THAT YOGA TRAINING MODULATES ACTH LEVEL IN CONCOMITANT WITH REDUCTION IN CORTISOL LEVEL IN FEMALE PATIENTS WITH MS. 2017 4 683 53 EFFECT OF AN 8-WEEK YOGA-BASED LIFESTYLE INTERVENTION ON PSYCHO-NEURO-IMMUNE AXIS, DISEASE ACTIVITY, AND PERCEIVED QUALITY OF LIFE IN RHEUMATOID ARTHRITIS PATIENTS: A RANDOMIZED CONTROLLED TRIAL. VARIOUS EXTERNAL STRESSORS AND ENVIRONMENTAL CHALLENGES LEAD TO THE PROVOCATION OF THE IMMUNE SYSTEM IN AUTOIMMUNE DISEASES LIKE RHEUMATOID ARTHRITIS (RA). THE INAPPROPRIATE IMMUNE RESPONSE FURTHER TRIGGERS THE CASCADE OF INFLAMMATORY CHANGES RESULTING IN PRECIPITATION OF SYMPTOMS AND HAMPERS QUALITY OF LIFE (QOL). THE UNDERLYING PSYCHO-SOMATIC COMPONENT OF THE DISEASE REQUIRES A HOLISTIC APPROACH TO ITS TREATMENT DIMENSION RATHER THAN THE USE OF PHARMACOTHERAPY. THE APPLICABILITY OF MIND-BODY INTERVENTIONS HAS BECOME ESSENTIAL IN TODAY'S FAST-PACED LIFE. YOGA, A MIND-BODY TECHNIQUE, ALTERS THE MIND'S CAPACITY TO FACILITATE SYSTEMIC FUNCTIONING AT MULTIPLE ORGAN SYSTEM LEVELS. HENCE, WE CONDUCTED THIS STUDY TO EVALUATE THE IMPACT OF 8 WEEKS OF A YOGA-BASED LIFESTYLE INTERVENTION (YBLI) ON PSYCHO-NEURO-IMMUNE MARKERS, GENE EXPRESSION PATTERNS, AND QOL IN RA PATIENTS ON ROUTINE MEDICAL THERAPY. A TOTAL OF 66 PATIENTS WERE RANDOMIZED INTO TWO GROUPS: YOGA GROUP OR NON-YOGA GROUP AND WERE ASSESSED FOR A PANEL OF INFLAMMATORY CYTOKINES (IL-6, IL-17A, TNF-ALPHA, AND TGF-BETA), MIND-BODY COMMUNICATIVE MARKERS (BDNF, DHEAS, BETA-ENDORPHIN, AND SIRTUIN) AND TRANSCRIPT LEVELS OF VARIOUS GENES (IL-6, TNF-ALPHA, NFKB1, TGF-BETA, AND CTLA4). WE ASSESSED DISEASE ACTIVITY AND QOL USING THE DAS28-ESR AND WHOQOL-BREF QUESTIONNAIRE, RESPECTIVELY. YOGA GROUP OBSERVED SIGNIFICANT IMPROVEMENTS IN THE LEVELS OF MARKERS, WHICH INFLUENCED THE PSYCHO-NEURO-IMMUNE AXIS (P < 0.001) WITH AN ESTIMATED EFFECT SIZE FROM SMALL TO MEDIUM RANGE. IN THE YOGA GROUP, THERE WAS A SIGNIFICANT REDUCTION IN DAS28-ESR (P < 0.001) AND IMPROVEMENT SEEN IN THE PHYSICAL HEALTH, PSYCHOLOGICAL, SOCIAL RELATIONSHIPS DOMAINS (P < 0.001) OF QOL, EXCEPT ENVIRONMENTAL (P > 0.05). THE YOGA GROUP SHOWED DOWNREGULATION OF IL-6, TNF-ALPHA, AND CTLA4 AND UPREGULATION OF TGF-BETA. THESE RESULTS SUGGEST THAT A DECREASE IN DISEASE ACTIVITY AFTER YOGA PRACTICE IS ASSOCIATED WITH A SIGNIFICANT REDUCTION IN INFLAMMATORY CYTOKINES, THE ELEVATION OF MIND-BODY COMMUNICATIVE MARKERS, AND NORMALIZATION OF VARIOUS TRANSCRIPT LEVELS, WHICH IMPROVED QOL. THUS THE ADOPTION OF YBLI IMPROVES CLINICAL OUTCOME IN RA, AND DECREASES SYSTEMIC INFLAMMATION BY ITS BENEFICIAL EFFECTS ON PSYCHO-NEURO-IMMUNE AXIS AND NORMALIZATION OF DYSREGULATED TRANSCRIPTS. THUS YBLI MAY BE USED FOR RA PATIENTS AS AN ADJUNCTIVE THERAPY. 2020 5 2038 54 TELOMERASE ACTIVITY AND CELLULAR AGING MIGHT BE POSITIVELY MODIFIED BY A YOGA-BASED LIFESTYLE INTERVENTION. OBJECTIVES: RECENT STUDIES SHOWED THAT A BRIEF YOGA-BASED LIFESTYLE INTERVENTION WAS EFFICACIOUS IN REDUCING LEVELS OF OXIDATIVE STRESS AND CELLULAR AGING IN OBESE MEN. THE OBJECTIVE OF THIS CASE REPORT WAS TO ASSESS THE EFFICACY OF THIS INTERVENTION IN REDUCING THE LEVELS OF BIOCHEMICAL MARKERS OF CELLULAR AGEING, OXIDATIVE STRESS, AND INFLAMMATION AT BASELINE (DAY 0), AT THE END OF ACTIVE INTERVENTION (DAY 10), AND FOLLOW-UP AT DAY 90. DESIGN: SINGLE CASE REPORT FROM A PROSPECTIVE ONGOING STUDY WITH PRE-POST DESIGN ASSESSING THE LEVEL OF VARIOUS MARKERS OF CELLULAR AGING. SETTING: INTEGRAL HEALTH CLINIC, AN OUTPATIENT FACILITY CONDUCTING MEDITATION AND YOGA-BASED LIFESTYLE INTERVENTION PROGRAMS FOR MANAGEMENT OF CHRONIC DISEASES. PATIENT: A 31-YEAR-OLD MAN WITH CLASS I OBESITY (BODY-MASS INDEX, 29.5 KG/M(2)) WHO PRESENTED TO THE MEDICINE OUTPATIENT DEPARTMENT AT ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI, INDIA, WITH A HISTORY OF FATIGUE, DIFFICULTY LOSING WEIGHT, AND LACK OF MOTIVATION. HE NOTED A MARKED DECREASE IN HIS ENERGY LEVEL, PARTICULARLY IN THE AFTERNOON. INTERVENTION: A PRETESTED INTERVENTION PROGRAM INCLUDED ASANAS (POSTURES), PRANAYAMA (BREATHING EXERCISES), STRESS MANAGEMENT, GROUP DISCUSSIONS, LECTURES, AND INDIVIDUALIZED ADVICE. RESULTS: FROM BASELINE (DAY 0) TO DAY 90, THE ACTIVITY OF TELOMERASE AND LEVELS OF BETA-ENDORPHINS, PLASMA CORTISOL, AND INTERLEUKIN-6 INCREASED, AND A SUSTAINED REDUCTION IN OXIDATIVE STRESS MARKERS, SUCH AS REACTIVE OXYGEN SPECIES AND 8-HYDROXY-2-DEOXY-GUANOSINE LEVELS. CONCLUSIONS: ADOPTING YOGA/MEDITATION-BASED LIFESTYLE MODIFICATION CAUSES REVERSAL OF MARKERS OF AGING, MAINLY OXIDATIVE STRESS, TELOMERASE ACTIVITY, AND OXIDATIVE DNA DAMAGE. THIS MAY NOT ONLY DELAY AGING AND PROLONG A YOUTHFUL HEALTHY LIFE BUT ALSO DELAY OR PREVENT ONSET OF SEVERAL LIFESTYLE-RELATED DISEASES, OF WHICH OXIDATIVE STRESS AND INFLAMMATION ARE THE CHIEF CAUSE. THIS REPORT SUGGESTS THIS SIMPLE LIFESTYLE INTERVENTION MAY BE THERAPEUTIC FOR OXIDATIVE DNA DAMAGE AND OXIDATIVE STRESS. 2015 6 2608 16 YOGA FOR PSYCHIATRIC DISORDERS: FROM FAD TO EVIDENCE-BASED INTERVENTION? THERE IS GROWING EVIDENCE FOR YOGA'S NEUROBIOLOGICAL EFFECTS IN PEOPLE WITH PSYCHIATRIC DISORDERS. POSTULATED MECHANISMS OF ACTION INCLUDE: (A) MODULATION OF THE HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS; (B) ENHANCEMENT OF GABAERGIC NEUROTRANSMISSION; (C) AUTONOMIC MODULATION; AND (D) NEUROENDOCRINOLOGICAL EFFECTS. YOGA AS A THERAPEUTIC INTERVENTION IN PSYCHIATRIC DISORDERS APPEARS PROMISING AND MERITS FURTHER ATTENTION IN CLINICAL PRACTICE AND RESEARCH. 2020 7 2847 38 YOGA, MEDITATION AND MIND-BODY HEALTH: INCREASED BDNF, CORTISOL AWAKENING RESPONSE, AND ALTERED INFLAMMATORY MARKER EXPRESSION AFTER A 3-MONTH YOGA AND MEDITATION RETREAT. THIRTY-EIGHT INDIVIDUALS (MEAN AGE: 34.8 YEARS OLD) PARTICIPATING IN A 3-MONTH YOGA AND MEDITATION RETREAT WERE ASSESSED BEFORE AND AFTER THE INTERVENTION FOR PSYCHOMETRIC MEASURES, BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF), CIRCADIAN SALIVARY CORTISOL LEVELS, AND PRO- AND ANTI-INFLAMMATORY CYTOKINES. PARTICIPATION IN THE RETREAT WAS FOUND TO BE ASSOCIATED WITH DECREASES IN SELF-REPORTED ANXIETY AND DEPRESSION AS WELL AS INCREASES IN MINDFULNESS. AS HYPOTHESIZED, INCREASES IN THE PLASMA LEVELS OF BDNF AND INCREASES IN THE MAGNITUDE OF THE CORTISOL AWAKENING RESPONSE (CAR) WERE ALSO OBSERVED. THE NORMALIZED CHANGE IN BDNF LEVELS WAS INVERSELY CORRELATED WITH BSI-18 ANXIETY SCORES AT BOTH THE PRE-RETREAT (R = 0.40, P < 0.05) AND POST-RETREAT (R = 0.52, P < 0.005) SUCH THAT THOSE WITH GREATER ANXIETY SCORES TENDED TO EXHIBIT SMALLER PRE- TO POST-RETREAT INCREASES IN PLASMA BDNF LEVELS. IN LINE WITH A HYPOTHESIZED DECREASE IN INFLAMMATORY PROCESSES RESULTING FROM THE YOGA AND MEDITATION PRACTICES, WE FOUND THAT THE PLASMA LEVEL OF THE ANTI-INFLAMMATORY CYTOKINE INTERLEUKIN-10 WAS INCREASED AND THE PRO-INFLAMMATORY CYTOKINE INTERLEUKIN-12 WAS REDUCED AFTER THE RETREAT. CONTRARY TO OUR INITIAL HYPOTHESES, PLASMA LEVELS OF OTHER PRO-INFLAMMATORY CYTOKINES, INCLUDING INTERFERON GAMMA (IFN-GAMMA), TUMOR NECROSIS FACTOR (TNF-ALPHA), INTERLEUKIN-1BETA (IL-1BETA), INTERLEUKIN-6 (IL-6), AND INTERLEUKIN-8 (IL-8) WERE INCREASED AFTER THE RETREAT. GIVEN EVIDENCE FROM PREVIOUS STUDIES OF THE POSITIVE EFFECTS OF MEDITATIVE PRACTICES ON MENTAL FITNESS, AUTONOMIC HOMEOSTASIS AND INFLAMMATORY STATUS, WE HYPOTHESIZE THAT THESE FINDINGS ARE RELATED TO THE MEDITATIVE PRACTICES THROUGHOUT THE RETREAT; HOWEVER, SOME OF THE OBSERVED CHANGES MAY ALSO BE RELATED TO OTHER ASPECTS OF THE RETREAT SUCH AS PHYSICAL EXERCISE-RELATED COMPONENTS OF THE YOGA PRACTICE AND DIET. WE HYPOTHESIZE THAT THE PATTERNS OF CHANGE OBSERVED HERE REFLECT MIND-BODY INTEGRATION AND WELL-BEING. THE INCREASED BDNF LEVELS OBSERVED IS A POTENTIAL MEDIATOR BETWEEN MEDITATIVE PRACTICES AND BRAIN HEALTH, THE INCREASED CAR IS LIKELY A REFLECTION OF INCREASED DYNAMIC PHYSIOLOGICAL AROUSAL, AND THE RELATIONSHIP OF THE DUAL ENHANCEMENT OF PRO- AND ANTI-INFLAMMATORY CYTOKINE CHANGES TO HEALTHY IMMUNOLOGIC FUNCTIONING IS DISCUSSED. 2017 8 1639 27 MODULATION OF IMMUNE RESPONSES IN STRESS BY YOGA. STRESS IS A CONSTANT FACTOR IN TODAY'S FASTPACED LIFE THAT CAN JEOPARDIZE OUR HEALTH IF LEFT UNCHECKED. IT IS ONLY IN THE LAST HALF CENTURY THAT THE ROLE OF STRESS IN EVERY AILMENT FROM THE COMMON COLD TO AIDS HAS BEEN EMPHASIZED, AND THE MECHANISMS INVOLVED IN THIS PROCESS HAVE BEEN STUDIED. STRESS INFLUENCES THE IMMUNE RESPONSE PRESUMABLY THROUGH THE ACTIVATION OF THE HYPOTHALAMIC-PITUITARY ADRENAL AXIS, HYPOTHALAMIC PITUITARY-GONADAL AXIS, AND THE SYMPATHETIC-ADRENAL-MEDULLARY SYSTEM. VARIOUS NEUROTRANSMITTERS, NEUROPEPTIDES, HORMONES, AND CYTOKINES MEDIATE THESE COMPLEX BIDIRECTIONAL INTERACTIONS BETWEEN THE CENTRAL NERVOUS SYSTEM (CNS) AND THE IMMUNE SYSTEM. THE EFFECTS OF STRESS ON THE IMMUNE RESPONSES RESULT IN ALTERATIONS IN THE NUMBER OF IMMUNE CELLS AND CYTOKINE DYSREGULATION. VARIOUS STRESS MANAGEMENT STRATEGIES SUCH AS MEDITATION, YOGA, HYPNOSIS, AND MUSCLE RELAXATION HAVE BEEN SHOWN TO REDUCE THE PSYCHOLOGICAL AND PHYSIOLOGICAL EFFECTS OF STRESS IN CANCERS AND HIV INFECTION. THIS REVIEW AIMS TO DISCUSS THE EFFECT OF STRESS ON THE IMMUNE SYSTEM AND EXAMINE HOW RELAXATION TECHNIQUES SUCH AS YOGA AND MEDITATION COULD REGULATE THE CYTOKINE LEVELS AND HENCE, THE IMMUNE RESPONSES DURING STRESS. 2008 9 783 47 EFFECT OF YOGA BASED LIFESTYLE INTERVENTION ON STATE AND TRAIT ANXIETY. CONSIDERABLE EVIDENCE EXISTS FOR THE PLACE OF MIND BODY MEDICINE IN THE TREATMENT OF ANXIETY DISORDERS. EXCESSIVE ANXIETY IS MALADAPTIVE. IT IS OFTEN CONSIDERED TO BE THE MAJOR COMPONENT OF UNHEALTHY LIFESTYLE THAT CONTRIBUTES SIGNIFICANTLY TO THE PATHOGENESIS OF NOT ONLY PSYCHIATRIC BUT ALSO MANY OTHER SYSTEMIC DISORDERS. AMONG THE APPROACHES TO REDUCE THE LEVEL OF ANXIETY HAS BEEN THE SEARCH FOR HEALTHY LIFESTYLES. THE AIM OF THE STUDY WAS TO STUDY THE SHORT-TERM IMPACT OF A COMPREHENSIVE BUT BRIEF LIFESTYLE INTERVENTION, BASED ON YOGA, ON ANXIETY LEVELS IN NORMAL AND DISEASED SUBJECTS. THE STUDY WAS THE RESULT OF OPERATIONAL RESEARCH CARRIED OUT IN THE INTEGRAL HEALTH CLINIC (IHC) AT THE DEPARTMENT OF PHYSIOLOGY OF ALL INDIA INSTITUTE OF MEDICAL SCIENCES. THE SUBJECTS HAD HISTORY OF HYPERTENSION, CORONARY ARTERY DISEASE, DIABETES MELLITUS, OBESITY, PSYCHIATRIC DISORDERS (DEPRESSION, ANXIETY, 'STRESS'), GASTROINTESTINAL PROBLEMS (NON ULCER DYSPEPSIA, DUODENAL ULCERS, IRRITABLE BOWEL DISEASE, CROHN'S DISEASE, CHRONIC CONSTIPATION) AND THYROID DISORDERS (HYPERTHYROIDISM AND HYPOTHYROIDISM). THE INTERVENTION CONSISTED OF ASANAS, PRANAYAMA, RELAXATION TECHNIQUES, GROUP SUPPORT, INDIVIDUALIZED ADVICE, AND LECTURES AND FILMS ON PHILOSOPHY OF YOGA, THE PLACE OF YOGA IN DAILY LIFE, MEDITATION, STRESS MANAGEMENT, NUTRITION, AND KNOWLEDGE ABOUT THE ILLNESS. THE OUTCOME MEASURES WERE ANXIETY SCORES, TAKEN ON THE FIRST AND LAST DAY OF THE COURSE. ANXIETY SCORES, BOTH STATE AND TRAIT ANXIETY WERE SIGNIFICANTLY REDUCED. AMONG THE DISEASED SUBJECTS SIGNIFICANT IMPROVEMENT WAS SEEN IN THE ANXIETY LEVELS OF PATIENTS OF HYPERTENSION, CORONARY ARTERY DISEASE, OBESITY, CERVICAL SPONDYLITIS AND THOSE WITH PSYCHIATRIC DISORDERS. THE OBSERVATIONS SUGGEST THAT A SHORT EDUCATIONAL PROGRAMME FOR LIFESTYLE MODIFICATION AND STRESS MANAGEMENT LEADS TO REMARKABLE REDUCTION IN THE ANXIETY SCORES WITHIN A PERIOD OF 10 DAYS. 2006 10 2854 43 YOGA- AND MEDITATION-BASED LIFESTYLE INTERVENTION INCREASES NEUROPLASTICITY AND REDUCES SEVERITY OF MAJOR DEPRESSIVE DISORDER: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: CURRENT INTERVENTIONS FOR MAJOR DEPRESSIVE DISORDER (MDD) ARE SUBOPTIMAL, AND ONLY ONE THIRD RESPOND TO THEM ON INITIAL TREATMENT. NEUROPLASTICITY THEORIES ARE THE BASIS FOR SEVERAL EMERGING TREATMENTS. EVIDENCE ON THE IMPACT OF YOGA, A WELL-KNOWN MIND-BODY INTERVENTION, ON NEUROPLASTICITY IN MDD IS LIMITED. OBJECTIVES: TO DETERMINE THE EFFECTS OF 12-WEEK YOGA- AND MEDITATION-BASED LIFESTYLE INTERVENTION (YMLI) ON DEPRESSION SEVERITY AND SYSTEMIC BIOMARKERS OF NEUROPLASTICITY IN ADULT MDD PATIENTS ON ROUTINE DRUG TREATMENT. METHODS: A TOTAL OF 58 MDD PATIENTS WERE RANDOMIZED INTO YOGA OR CONTROL GROUP. THE SEVERITY OF DEPRESSION WAS ASSESSED WITH BECK DEPRESSION INVENTORY-II SCALE (BDI-II). BLOOD SAMPLES WERE COLLECTED BEFORE AND AFTER INTERVENTION FOR THE MEASUREMENT OF THE BIOMARKERS THAT CHARACTERIZE NEUROPLASTICITY, INCLUDING MIND-BODY COMMUNICATIVE AND CELLULAR HEALTH BIOMARKERS. RESULTS: THERE WAS A SIGNIFICANT DECREASE [DIFFERENCE BETWEEN MEANS, (95% CI)] IN BDI-II SCORE [-5.83 (-7.27, -4.39), P < 0.001] AND SIGNIFICANT INCREASE IN BDNF (NG/ML) [5.48 (3.50, 7.46), P < 0.001] AFTER YMLI COMPARED TO CONTROL GROUP. YMLI SIGNIFICANTLY INCREASED DHEAS, SIRTUIN 1, AND TELOMERASE ACTIVITY LEVELS, AND DECREASED CORTISOL, AND IL-6 LEVELS, IN ADDITION TO DECREASING DNA DAMAGE AND BALANCING OXIDATIVE STRESS. MULTIPLE REGRESSION ANALYSES WERE USED TO ASSOCIATE NEUROPLASTICITY BIOMARKERS WITH DEPRESSION SEVERITY. A 'POST-INTERVENTION CHANGE IN BDNF' X 'GROUP' INTERACTION INDICATED THAT YOGA GROUP HAD MORE BDNF IN ASSOCIATION WITH LESS BDI-II SCORES RELATIVE TO CONTROLS. INCREASED SIRTUIN 1 AND TELOMERASE ACTIVITY AND DECREASED CORTISOL SIGNIFICANTLY PREDICTED THIS ASSOCIATION (ALL P < 0.05). CONCLUSION: THESE RESULTS SUGGEST THAT DECREASE IN DEPRESSION SEVERITY AFTER YMLI IN MDD IS ASSOCIATED WITH IMPROVED SYSTEMIC BIOMARKERS OF NEUROPLASTICITY. THUS YMLI CAN BE CONSIDERED AS A THERAPEUTIC INTERVENTION IN MDD MANAGEMENT. 2018 11 1590 15 MEDITATION AND YOGA CAN MODULATE BRAIN MECHANISMS THAT AFFECT BEHAVIOR AND ANXIETY-A MODERN SCIENTIFIC PERSPECTIVE. MEDITATION AND YOGA TECHNIQUES ARE RECEIVING INCREASED ATTENTION THROUGHOUT THE WORLD, DUE TO THE ACCUMULATION OF EVIDENCE BASED RESEARCH THAT PROVES THE DIRECT AND INDIRECT BENEFITS OF SUCH PRACTICES. BASED ON STUDIES CONDUCTED SO FAR, IT HAS BEEN FOUND THAT THE PRACTICE OF MEDITATION TRIGGERS NEUROTRANSMITTERS THAT MODULATE PSYCHOLOGICAL DISORDERS SUCH AS ANXIETY. THIS PAPER WILL REVIEW THE PSYCHOLOGICAL EFFECTS OF THE PRACTICE OF MEDITATION, THE ROLE OF NEUROTRANSMITTERS, AND STUDIES USING EEG AND FMRI. 2015 12 1191 25 EVOLUTION FROM FOUR MENTAL STATES TO THE HIGHEST STATE OF CONSCIOUSNESS: A NEUROPHYSIOLOGICAL BASIS OF MEDITATION AS DEFINED IN YOGA TEXTS. THIS CHAPTER PROVIDES A THEORETICAL INTRODUCTION TO STATES OF CONSCIOUSNESS AND REVIEWS NEUROSCIENTIFIC INVESTIGATIONS OF MEDITATION. THE DIFFERENT STATES OF CONSCIOUSNESS CONSIST OF FOUR MENTAL STATES, I.E., CANCALATA (RANDOM THINKING), EKAGRATA (NON-MEDITATIVE FOCUSING), DHARNA (FOCUSED MEDITATION), AND DHYANA (MEDITATION) AS DEFINED IN YOGA TEXTS. MEDITATION IS A SELF-REGULATED MENTAL PROCESS ASSOCIATED WITH DEEP RELAXATION AND INCREASED INTERNALIZED ATTENTION. SCIENTIFIC INVESTIGATIONS ON MEDITATION REPORTED CHANGES IN ELECTROPHYSIOLOGICAL SIGNALS AND NEUROIMAGING MEASURES. BUT MOST OUTCOMES OF MEDITATION STUDIES SHOWED INCONSISTENT RESULTS, THIS MAY BE DUE TO HETEROGENEITY IN MEDITATION METHODS AND TECHNIQUES EVOLVED IN THE LAST 200 YEARS. TRADITIONALLY, THE FEATURES OF MEDITATION INCLUDE THE CAPACITY TO SUSTAIN A HEIGHTENED AWARENESS OF THOUGHTS, BEHAVIORS, EMOTIONS, AND PERCEPTIONS. GENERALLY, MEDITATION INVOLVES NON-REACTIVE EFFORTLESS MONITORING OF THE CONTENT OF EXPERIENCE FROM MOMENT TO MOMENT. FOCUSED MEDITATION PRACTICE INVOLVES AWARENESS ON A SINGLE OBJECT AND OPEN MONITORING MEDITATION IS A NON-DIRECTIVE MEDITATION INVOLVED ATTENTION IN BREATHING, MANTRA, OR SOUND. THEREFORE, RESULTS OF FEW EMPIRICAL STUDIES OF ADVANCED MEDITATORS OR BEGINNERS REMAIN TENTATIVE. THIS IS AN ATTEMPT TO COMPILE THE MEDITATION-RELATED CHANGES IN ELECTROPHYSIOLOGICAL AND NEUROIMAGING PROCESSES AMONG EXPERIENCED AND NOVICE PRACTITIONERS. 2019 13 1640 37 MOLECULAR SIGNATURE OF THE IMMUNE RESPONSE TO YOGA THERAPY IN STRESS-RELATED CHRONIC DISEASE CONDITIONS: AN INSIGHT. THE WORLD HEALTH ORGANIZATION DEFINES HEALTH AS COMPLETE WELL-BEING IN TERMS OF PHYSICAL, MENTAL AND SOCIAL, AND NOT MERELY THE ABSENCE OF DISEASE. TO ATTAIN THIS, INDIVIDUAL SHOULD ADAPT AND SELF-MANGE THE SOCIAL, PHYSICAL AND EMOTIONAL CHALLENGES OF LIFE. EXPOSURE TO CHRONIC STRESS DUE TO URBANIZATION, WORK STRESS, NUCLEAR FAMILY, POLLUTION, UNHEALTHY FOOD HABITS, LIFESTYLE, ACCIDENTAL DEATH IN THE FAMILY, AND NATURAL CALAMITIES ARE THE TRIGGERING FACTORS, LEADING TO HORMONAL IMBALANCE AND INFLAMMATION IN THE TISSUE. THE RELATIONSHIP BETWEEN STRESS AND ILLNESS IS COMPLEX; ALL CHRONIC ILLNESSES SUCH AS CARDIOVASCULAR DISEASE AND ASTHMA HAVE THEIR ROOT IN CHRONIC STRESS ATTRIBUTED BY INFLAMMATION. IN RECENT TIMES, YOGA THERAPY HAS EMERGED AS AN IMPORTANT COMPLEMENTARY ALTERNATIVE MEDICINE FOR MANY HUMAN DISEASES. YOGA THERAPY HAS A POSITIVE IMPACT ON MIND AND BODY; IT ACTS BY INCORPORATING APPROPRIATE BREATHING TECHNIQUES AND MINDFULNESS TO ATTAIN CONSCIOUS DIRECTION OF OUR AWARENESS OF THE PRESENT MOMENT BY MEDITATION, WHICH HELPS ACHIEVE HARMONY BETWEEN THE BODY AND MIND. STUDIES HAVE ALSO DEMONSTRATED THE IMPORTANT REGULATORY EFFECTS OF YOGA THERAPY ON BRAIN STRUCTURE AND FUNCTIONS. DESPITE THESE ADVANCES, THE CELLULAR AND MOLECULAR MECHANISMS BY WHICH YOGA THERAPY RENDERS ITS BENEFICIAL EFFECTS ARE INADEQUATELY KNOWN. A GROWING BODY OF EVIDENCE SUGGESTS THAT YOGA THERAPY HAS IMMUNOMODULATORY EFFECTS. HOWEVER, THE PRECISE MECHANISTIC BASIS HAS NOT BEEN ADDRESSED EMPIRICALLY. IN THIS REVIEW, WE HAVE ATTEMPTED TO HIGHLIGHT THE EFFECT OF YOGA THERAPY ON IMMUNE SYSTEM FUNCTIONING WITH AN AIM TO IDENTIFY IMPORTANT IMMUNOLOGICAL SIGNATURES THAT INDEX THE EFFECT OF YOGA THERAPY. TOWARD THIS, WE HAVE SUMMARIZED THE AVAILABLE SCIENTIFIC EVIDENCE SHOWING POSITIVE IMPACTS OF YOGA THERAPY. FINALLY, WE HAVE EMPHASIZED THE EFFICACY OF YOGA IN IMPROVING PHYSICAL AND MENTAL WELL-BEING. YOGA HAS BEEN A PART OF INDIAN CULTURE AND TRADITION FOR LONG; NOW, THE TIME HAS COME TO SCIENTIFICALLY VALIDATE THIS AND IMPLEMENT THIS AS AN ALTERNATIVE TREATMENT METHOD FOR STRESS-RELATED CHRONIC DISEASE. 2020 14 2418 32 YOGA AND MENOPAUSAL TRANSITION. WITH INCREASED LIFE EXPECTANCY, TODAY, WOMEN SPEND ONE-THIRD OF THEIR LIFE AFTER MENOPAUSE. THUS MORE ATTENTION IS NEEDED TOWARDS PERI- AND POST-MENOPAUSAL SYMPTOMS. ESTROGEN REPLACEMENT THERAPY IS THE MOST EFFECTIVE TREATMENT, HOWEVER, IT HAS ITS OWN LIMITATIONS. THE PRESENT NEED IS TO EXPLORE NEW OPTIONS FOR THE MANAGEMENT OF MENOPAUSAL SYMPTOMS. YOGIC LIFE STYLE IS A WAY OF LIVING WHICH AIMS TO IMPROVE THE BODY, MIND AND DAY TO DAY LIFE OF INDIVIDUALS. THE MOST COMMONLY PERFORMED YOGA PRACTICES ARE POSTURES (ASANA), CONTROLLED BREATHING (PRANAYAMA), AND MEDITATION (DHYANA). YOGA HAS BEEN UTILIZED AS A THERAPEUTIC TOOL TO ACHIEVE POSITIVE HEALTH AND CONTROL AND CURE DISEASES. THE EXACT MECHANISM AS TO HOW YOGA HELPS IN VARIOUS DISEASE STATES IS NOT KNOWN. THERE COULD BE NEURO-HORMONAL PATHWAYS WITH A SELECTIVE EFFECT IN EACH PATHOLOGICAL SITUATION. THERE HAVE BEEN MULTIPLE STUDIES THAT HAVE COMBINED THE MANY ASPECTS OF YOGA INTO A GENERAL YOGA SESSION IN ORDER TO INVESTIGATE ITS EFFECTS ON MENOPAUSAL SYMPTOMS. INTEGRATED APPROACH OF YOGA THERAPY CAN IMPROVE HOT FLUSHES AND NIGHT SWEATS. THERE IS INCREASING EVIDENCE SUGGESTING THAT EVEN THE SHORT-TERM PRACTICE OF YOGA CAN DECREASE BOTH PSYCHOLOGICAL AND PHYSIOLOGICAL RISK FACTORS FOR CARDIOVASCULAR DISEASE (CVD). STUDIES CONCLUDE THAT OUR AGE OLD THERAPY, YOGA, IS FAIRLY EFFECTIVE IN MANAGING MENOPAUSAL SYMPTOMS. 2010 15 1934 22 ROLE OF YOGA IN STRESS MANAGEMENT. THE STATE OF THE MIND AND THAT OF THE BODY ARE INTIMATELY RELATED. IF THE MIND IS RELAXED, THE MUSCLES IN THE BODY WILL ALSO BE RELAXED. STRESS PRODUCES A STATE OF PHYSICAL AND MENTAL TENSION. YOGA, DEVELOPED THOUSANDS OF YEARS AGO, IS RECOGNIZED AS A FORM OF MIND-BODY MEDICINE. IN YOGA, PHYSICAL POSTURES AND BREATHING EXERCISES IMPROVE MUSCLE STRENGTH, FLEXIBILITY, BLOOD CIRCULATION AND OXYGEN UPTAKE AS WELL AS HORMONE FUNCTION. IN ADDITION, THE RELAXATION INDUCED BY MEDITATION HELPS TO STABILIZE THE AUTONOMIC NERVOUS SYSTEM WITH A TENDENCY TOWARDS PARASYMPATHETIC DOMINANCE. PHYSIOLOGICAL BENEFITS WHICH FOLLOW, HELP YOGA PRACTITIONERS BECOME MORE RESILIENT TO STRESSFUL CONDITIONS AND REDUCE A VARIETY OF IMPORTANT RISK FACTORS FOR VARIOUS DISEASES, ESPECIALLY CARDIO-RESPIRATORY DISEASES. 2004 16 1789 31 PRELIMINARY INDICATIONS OF THE EFFECT OF A BRIEF YOGA INTERVENTION ON MARKERS OF INFLAMMATION AND DNA METHYLATION IN CHRONICALLY STRESSED WOMEN. YOGA IS ASSOCIATED WITH REDUCED STRESS AND INCREASED WELL-BEING, ALTHOUGH THE MOLECULAR BASIS FOR THESE BENEFITS IS NOT CLEAR. MOUNTING EVIDENCE IMPLICATES THE IMMUNE RESPONSE, WITH CURRENT STUDIES FOCUSED ON PROTEIN IMMUNE MARKERS (SUCH AS CYTOKINES) IN CLINICAL POPULATIONS. TO EXPLORE THE MOLECULAR IMPACT, THIS PILOT STUDY USES A SUBSAMPLE (N=28) FROM A RANDOMISED WAITLIST CONTROL TRIAL INVESTIGATING THE IMPACT OF AN 8-WEEK YOGA INTERVENTION IN A COMMUNITY POPULATION OF WOMEN REPORTING PSYCHOLOGICAL DISTRESS (N=116). WE MEASURED INTERLEUKIN-6 (IL-6), TUMOUR NECROSIS FACTOR (TNF) AND C-REACTIVE PROTEIN (CRP) PROTEIN LEVELS, AND THE DNA METHYLATION OF THESE GENES AND THE GLOBAL INDICATOR, LINE-1. CORRELATIONS BETWEEN THESE AND PSYCHOLOGICAL VARIABLES WERE EXPLORED, IDENTIFYING MODERATE CORRELATIONS WITH CRP PROTEIN LEVELS, AND METHYLATION OF IL-6, CRP AND LINE-1. MANY CYTOKINE SAMPLES WERE BELOW DETECTION, HOWEVER A MANN-WHITNEY U DEMONSTRATED A TREND OF MODERATE BETWEEN-GROUP EFFECT FOR ELEVATED IL-6 IN THE YOGA GROUP. METHYLATION ANALYSES APPLIED CROSS-SECTIONAL AND NON-CONTROLLED LONGITUDINAL ANALYSES. WAIST-TO-HEIGHT RATIO AND AGE WERE COVARIED. WE DEMONSTRATED REDUCED METHYLATION OF THE TNF REGION IN THE YOGA GROUP RELATIVE TO THE WAITLIST CONTROL GROUP. NO OTHER GENES DEMONSTRATED A SIGNIFICANT DIFFERENCE. LONGITUDINAL ANALYSIS FURTHER SUPPORTED THESE RESULTS. THIS STUDY IS ONE OF THE FIRST TO EXPLORE YOGA AND IMMUNOLOGICAL MARKERS IN A NON-CLINICAL POPULATION, AND IS THE FIRST STUDY TO EXPLORE DNA METHYLATION. THESE FINDINGS INDICATE THAT FURTHER RESEARCH INTO MOLECULAR IMPACT OF YOGA ON MARKERS OF IMMUNE FUNCTION IS WARRANTED, WITH LARGER STUDIES REQUIRED. 2016 17 39 44 A BRIEF BUT COMPREHENSIVE LIFESTYLE EDUCATION PROGRAM BASED ON YOGA REDUCES RISK FACTORS FOR CARDIOVASCULAR DISEASE AND DIABETES MELLITUS. OBJECTIVES: THE OBJECTIVE OF THE STUDY WAS TO STUDY THE SHORT-TERM IMPACT OF A BRIEF LIFESTYLE INTERVENTION BASED ON YOGA ON SOME OF THE BIOCHEMICAL INDICATORS OF RISK FOR CARDIOVASCULAR DISEASE AND DIABETES MELLITUS. DESIGN: THE VARIABLES OF INTEREST WERE MEASURED AT THE BEGINNING (DAY 1) AND END (DAY 10) OF THE INTERVENTION USING A PRE-POST DESIGN. SETTING: THE STUDY IS THE RESULT OF OPERATIONAL RESEARCH CARRIED OUT IN OUR INTEGRAL HEALTH CLINIC (IHC). THE IHC IS AN OUTPATIENT FACILITY WHICH CONDUCTS 8-DAY LIFESTYLE MODIFICATION PROGRAMS BASED ON YOGA FOR PREVENTION AND MANAGEMENT OF CHRONIC DISEASE. A NEW COURSE BEGINS EVERY ALTERNATE WEEK OF THE YEAR. SUBJECTS: THE STUDY IS BASED ON DATA COLLECTED ON 98 SUBJECTS (67 MALE, 31 FEMALE), AGES 20-74 YEARS, WHO ATTENDED ONE OF OUR PROGRAMS. THE SUBJECTS WERE A HETEROGENEOUS GROUP OF PATIENTS WITH HYPERTENSION, CORONARY ARTERY DISEASE, DIABETES MELLITUS, AND A VARIETY OF OTHER ILLNESSES. INTERVENTION: THE INTERVENTION CONSISTED OF ASANAS (POSTURES), PRANAYAMA (BREATHING EXERCISES), RELAXATION TECHNIQUES, GROUP SUPPORT, INDIVIDUALIZED ADVICE, LECTURES AND FILMS ON THE PHILOSOPHY OF YOGA AND THE PLACE OF YOGA IN DAILY LIFE, MEDITATION, STRESS MANAGEMENT, NUTRITION, AND KNOWLEDGE ABOUT THE ILLNESS. OUTCOME MEASURES: THE OUTCOME MEASURES WERE FASTING PLASMA GLUCOSE AND SERUM LIPOPROTEIN PROFILE. THESE VARIABLES WERE DETERMINED IN FASTING BLOOD SAMPLES, TAKEN ON THE FIRST AND LAST DAY OF THE COURSE. RESULTS: FASTING PLASMA GLUCOSE, SERUM TOTAL CHOLESTEROL, LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL, VERY- LDL CHOLESTEROL, THE RATIO OF TOTAL CHOLESTEROL TO HIGH DENSITY LIPOPROTEIN (HDL) CHOLESTEROL, AND TOTAL TRIGLYCERIDES WERE SIGNIFICANTLY LOWER, AND HDL CHOLESTEROL SIGNIFICANTLY HIGHER, ON THE LAST DAY OF THE COURSE COMPARED TO THE FIRST DAY OF THE COURSE. THE CHANGES WERE MORE MARKED IN SUBJECTS WITH HYPERGLYCEMIA OR HYPERCHOLESTEROLEMIA. CONCLUSIONS: THE OBSERVATIONS SUGGEST THAT A SHORT LIFESTYLE MODIFICATION AND STRESS MANAGEMENT EDUCATION PROGRAM LEADS TO FAVORABLE METABOLIC EFFECTS WITHIN A PERIOD OF 9 DAYS. 2005 18 2531 24 YOGA EFFECTS ON BRAIN HEALTH: A SYSTEMATIC REVIEW OF THE CURRENT LITERATURE. YOGA IS THE MOST POPULAR COMPLEMENTARY HEALTH APPROACH PRACTICED BY ADULTS IN THE UNITED STATES. IT IS AN ANCIENT MIND AND BODY PRACTICE WITH ORIGINS IN INDIAN PHILOSOPHY. YOGA COMBINES PHYSICAL POSTURES, RHYTHMIC BREATHING AND MEDITATIVE EXERCISE TO OFFER THE PRACTITIONERS A UNIQUE HOLISTIC MIND-BODY EXPERIENCE. WHILE THE HEALTH BENEFITS OF PHYSICAL EXERCISE ARE WELL ESTABLISHED, IN RECENT YEARS, THE ACTIVE ATTENTIONAL COMPONENT OF BREATHING AND MEDITATION PRACTICE HAS GARNERED INTEREST AMONG EXERCISE NEUROSCIENTISTS. AS THE SCIENTIFIC EVIDENCE FOR THE PHYSICAL AND MENTAL HEALTH BENEFITS OF YOGA CONTINUES TO GROW, THIS ARTICLE AIMS TO SUMMARIZE THE CURRENT KNOWLEDGE OF YOGA PRACTICE AND ITS DOCUMENTED POSITIVE EFFECTS FOR BRAIN STRUCTURE AND FUNCTION, AS ASSESSED WITH MRI, FMRI, AND SPECT. WE REVIEWED 11 STUDIES EXAMINING THE EFFECTS OF YOGA PRACTICE ON THE BRAIN STRUCTURES, FUNCTION AND CEREBRAL BLOOD FLOW. COLLECTIVELY, THE STUDIES DEMONSTRATE A POSITIVE EFFECT OF YOGA PRACTICE ON THE STRUCTURE AND/OR FUNCTION OF THE HIPPOCAMPUS, AMYGDALA, PREFRONTAL CORTEX, CINGULATE CORTEX AND BRAIN NETWORKS INCLUDING THE DEFAULT MODE NETWORK (DMN). THE STUDIES OFFER PROMISING EARLY EVIDENCE THAT BEHAVIORAL INTERVENTIONS LIKE YOGA MAY HOLD PROMISE TO MITIGATE AGE-RELATED AND NEURODEGENERATIVE DECLINES AS MANY OF THE REGIONS IDENTIFIED ARE KNOWN TO DEMONSTRATE SIGNIFICANT AGE-RELATED ATROPHY. 2019 19 1873 23 RAPID GENE EXPRESSION CHANGES IN PERIPHERAL BLOOD LYMPHOCYTES UPON PRACTICE OF A COMPREHENSIVE YOGA PROGRAM. ONE OF THE MOST COMMON INTEGRATIVE MEDICINE (IM) MODALITIES IS YOGA AND RELATED PRACTICES. PREVIOUS WORK HAS SHOWN THAT YOGA MAY IMPROVE WELLNESS IN HEALTHY PEOPLE AND HAVE BENEFITS FOR PATIENTS. HOWEVER, THE MECHANISMS OF HOW YOGA MAY POSITIVELY AFFECT THE MIND-BODY SYSTEM ARE LARGELY UNKNOWN. HERE WE HAVE ASSESSED POSSIBLE RAPID CHANGES IN GLOBAL GENE EXPRESSION PROFILES IN THE PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) IN HEALTHY PEOPLE THAT PRACTICED EITHER A COMPREHENSIVE YOGA PROGRAM OR A CONTROL REGIMEN. THE EXPERIMENTAL SESSIONS INCLUDED GENTLE YOGA POSTURES, BREATHING EXERCISES, AND MEDITATION (SUDARSHAN KRIYA AND RELATED PRACTICES--SK&P) COMPARED WITH A CONTROL REGIMEN OF A NATURE WALK AND LISTENING TO RELAXING MUSIC. WE SHOW THAT THE SK&P PROGRAM HAS A RAPID AND SIGNIFICANTLY GREATER EFFECT ON GENE EXPRESSION IN PBMCS COMPARED WITH THE CONTROL REGIMEN. THESE DATA SUGGEST THAT YOGA AND RELATED PRACTICES RESULT IN RAPID GENE EXPRESSION ALTERATIONS WHICH MAY BE THE BASIS FOR THEIR LONGER TERM CELL BIOLOGICAL AND HIGHER LEVEL HEALTH EFFECTS. 2013 20 226 27 A SYSTEMATIC REVIEW OF RANDOMISED CONTROL TRIALS ON THE EFFECTS OF YOGA ON STRESS MEASURES AND MOOD. STRESS RELATED DISORDERS SUCH AS DEPRESSION AND ANXIETY ARE LEADING SOURCES OF DISABILITY WORLDWIDE, AND CURRENT TREATMENT METHODS SUCH AS CONVENTIONAL ANTIDEPRESSANT MEDICATIONS ARE NOT BENEFICIAL FOR ALL INDIVIDUALS. THERE IS EVIDENCE THAT YOGA HAS MOOD-ENHANCING PROPERTIES POSSIBLY RELATED TO ITS INHIBITORY EFFECTS ON PHYSIOLOGICAL STRESS AND INFLAMMATION, WHICH ARE FREQUENTLY ASSOCIATED WITH AFFECTIVE DISORDERS. HOWEVER THE BIOLOGICAL MECHANISMS VIA WHICH YOGA EXERTS ITS THERAPEUTIC MOOD-MODULATING EFFECTS ARE LARGELY UNKNOWN. THIS SYSTEMATIC REVIEW INVESTIGATES THE EFFECTS OF YOGA ON SYMPATHETIC NERVOUS SYSTEM AND HYPOTHALAMIC PITUITARY ADRENAL AXIS REGULATION MEASURES. IT FOCUSES ON STUDIES COLLECTING PHYSIOLOGICAL PARAMETERS SUCH AS BLOOD PRESSURE, HEART RATE, CORTISOL, PERIPHERAL CYTOKINE EXPRESSION AND/OR STRUCTURAL AND FUNCTIONAL BRAIN MEASURES IN REGIONS INVOLVED IN STRESS AND MOOD REGULATION. OVERALL THE 25 RANDOMISED CONTROL STUDIES DISCUSSED PROVIDE PRELIMINARY EVIDENCE TO SUGGEST THAT YOGA PRACTICE LEADS TO BETTER REGULATION OF THE SYMPATHETIC NERVOUS SYSTEM AND HYPOTHALAMIC-PITUITARY-ADRENAL SYSTEM, AS WELL AS A DECREASE IN DEPRESSIVE AND ANXIOUS SYMPTOMS IN A RANGE OF POPULATIONS. FURTHER RESEARCH IS WARRANTED TO CONFIRM THESE PRELIMINARY FINDINGS AND FACILITATE IMPLEMENTATION IN CLINICAL SETTINGS. 2015